Elanco Animal Health (ELAN) Tops Q1 EPS by 16c

Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.45, $0.16 better than the analyst estimate of $0.29. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.19 billion.

GUIDANCE:

Elanco Animal Health sees FY2023 EPS of $0.79-$0.83, versus the consensus of $0.78. Elanco Animal Health sees FY2023 revenue of $4.31-4.4 billion, versus the consensus of $4.33 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• TRNR agrees to acquire STEPR, raises 2026 revenue guidance to $50M
• UBS Reiterates Buy Rating on Smurfit Westrock (SW)